$BFLY
Butterfly Network, Inc.

2024 Q3 Form 10-Q Financial Statement

#000155837024014082 Filed on November 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $20.56M
YoY Change 33.33%
Cost Of Revenue $8.328M
YoY Change 37.9%
Gross Profit $12.23M
YoY Change 30.39%
Gross Profit Margin 59.5%
Selling, General & Admin $18.96M
YoY Change -7.84%
% of Gross Profit 154.99%
Research & Development $8.844M
YoY Change -27.09%
% of Gross Profit 72.3%
Depreciation & Amortization $2.618M
YoY Change -34.88%
% of Gross Profit 21.4%
Operating Expenses $29.48M
YoY Change -29.72%
Operating Profit -$17.25M
YoY Change -47.04%
Interest Expense $902.0K
YoY Change -52.53%
% of Operating Profit
Other Income/Expense, Net $1.675M
YoY Change -81.88%
Pretax Income -$16.87M
YoY Change -38.37%
Income Tax $58.00K
% Of Pretax Income
Net Earnings -$16.92M
YoY Change -38.16%
Net Earnings / Revenue -82.31%
Basic Earnings Per Share -$0.08
Diluted Earnings Per Share -$0.08
COMMON SHARES
Basic Shares Outstanding 212.8M
Diluted Shares Outstanding 212.8M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.76M
YoY Change -37.49%
Cash & Equivalents $93.76M
Short-Term Investments
Other Short-Term Assets $11.84M
YoY Change 8.65%
Inventory $73.27M
Prepaid Expenses
Receivables $20.62M
Other Receivables $0.00
Total Short-Term Assets $199.5M
YoY Change -25.72%
LONG-TERM ASSETS
Property, Plant & Equipment $21.18M
YoY Change -19.67%
Goodwill
YoY Change
Intangibles $9.266M
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.649M
YoY Change -12.43%
Total Long-Term Assets $65.78M
YoY Change 0.22%
TOTAL ASSETS
Total Short-Term Assets $199.5M
Total Long-Term Assets $65.78M
Total Assets $265.3M
YoY Change -20.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.651M
YoY Change -54.91%
Accrued Expenses $18.80M
YoY Change 3.27%
Deferred Revenue $16.43M
YoY Change 8.65%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.79M
YoY Change -5.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $10.93M
YoY Change 730.62%
Total Long-Term Liabilities $10.93M
YoY Change 730.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.79M
Total Long-Term Liabilities $10.93M
Total Liabilities $83.44M
YoY Change 8.64%
SHAREHOLDERS EQUITY
Retained Earnings -$784.0M
YoY Change 14.37%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $181.8M
YoY Change
Total Liabilities & Shareholders Equity $265.3M
YoY Change -20.63%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$16.92M
YoY Change -38.16%
Depreciation, Depletion And Amortization $2.618M
YoY Change -34.88%
Cash From Operating Activities -$7.920M
YoY Change -50.44%
INVESTING ACTIVITIES
Capital Expenditures $414.0K
YoY Change -60.57%
Acquisitions
YoY Change
Other Investing Activities $1.000K
YoY Change
Cash From Investing Activities -$413.0K
YoY Change -60.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -7.920M
Cash From Investing Activities -413.0K
Cash From Financing Activities 0.000
Net Change In Cash -8.333M
YoY Change -50.78%
FREE CASH FLOW
Cash From Operating Activities -$7.920M
Capital Expenditures $414.0K
Free Cash Flow -$8.334M
YoY Change -51.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities
dei Entity Central Index Key
EntityCentralIndexKey
0001804176
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39292
dei Entity Registrant Name
EntityRegistrantName
Butterfly Network, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4618156
dei Entity Address Address Line1
EntityAddressAddressLine1
1600 District Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Burlington
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01803
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
557-4800
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93758000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134437000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20621000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13418000
CY2024Q3 us-gaap Inventory Net
InventoryNet
73271000
CY2023Q4 us-gaap Inventory Net
InventoryNet
73022000
CY2024Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
4351000
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
2815000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7492000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7571000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
199493000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
231263000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21176000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25321000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9266000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10317000
CY2024Q3 bfly Vendor Advances Non Current
VendorAdvancesNonCurrent
15082000
CY2023Q4 bfly Vendor Advances Non Current
VendorAdvancesNonCurrent
15276000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14606000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15675000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5649000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6422000
CY2024Q3 us-gaap Assets
Assets
265272000
CY2023Q4 us-gaap Assets
Assets
304274000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3651000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5090000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16425000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15625000
CY2024Q3 bfly Accrued Purchase Commitments Current
AccruedPurchaseCommitmentsCurrent
131000
CY2023Q4 bfly Accrued Purchase Commitments Current
AccruedPurchaseCommitmentsCurrent
131000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
22585000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
23425000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
42792000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44271000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7035000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7394000
CY2024Q3 bfly Warrant Liability
WarrantLiability
1652000
CY2023Q4 bfly Warrant Liability
WarrantLiability
826000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21030000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22835000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10931000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8895000
CY2024Q3 us-gaap Liabilities
Liabilities
83440000
CY2023Q4 us-gaap Liabilities
Liabilities
84221000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
965839000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
949670000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-784029000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-729638000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
181832000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
220053000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265272000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
304274000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20561000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15421000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59705000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49384000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
8328000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
6039000
us-gaap Cost Of Revenue
CostOfRevenue
24609000
us-gaap Cost Of Revenue
CostOfRevenue
19991000
CY2024Q3 us-gaap Gross Profit
GrossProfit
12233000
CY2023Q3 us-gaap Gross Profit
GrossProfit
9382000
us-gaap Gross Profit
GrossProfit
35096000
us-gaap Gross Profit
GrossProfit
29393000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8844000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12130000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28975000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44409000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9607000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9012000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29713000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28776000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9353000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11560000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29868000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37239000
CY2024Q3 us-gaap Other Expenses
OtherExpenses
1675000
CY2023Q3 us-gaap Other Expenses
OtherExpenses
9243000
us-gaap Other Expenses
OtherExpenses
3639000
us-gaap Other Expenses
OtherExpenses
17848000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
29479000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
41945000
us-gaap Operating Expenses
OperatingExpenses
92195000
us-gaap Operating Expenses
OperatingExpenses
128272000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17246000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32563000
us-gaap Operating Income Loss
OperatingIncomeLoss
-57099000
us-gaap Operating Income Loss
OperatingIncomeLoss
-98879000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1221000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1903000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4023000
us-gaap Investment Income Interest
InvestmentIncomeInterest
5714000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
319000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
928000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1239000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3511000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
826000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3924000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
717000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-217000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
517000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-256000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16866000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27366000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54313000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-89497000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-16924000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-27368000
us-gaap Net Income Loss
NetIncomeLoss
-54391000
us-gaap Net Income Loss
NetIncomeLoss
-89579000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212774085
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212774085
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
206740234
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206740234
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211109792
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211109792
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
204749108
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
204749108
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
194280000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-16924000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4476000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
181832000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
277705000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-27368000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
92000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6990000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
257419000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
220053000
us-gaap Net Income Loss
NetIncomeLoss
-54391000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16169000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
181832000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
325360000
us-gaap Net Income Loss
NetIncomeLoss
-89579000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
228000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21409000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
257419000
us-gaap Profit Loss
ProfitLoss
-54391000
us-gaap Profit Loss
ProfitLoss
-89579000
bfly Depreciation Depletion Amortization And Impairments
DepreciationDepletionAmortizationAndImpairments
7835000
bfly Depreciation Depletion Amortization And Impairments
DepreciationDepletionAmortizationAndImpairments
8332000
us-gaap Paid In Kind Interest
PaidInKindInterest
926000
us-gaap Inventory Write Down
InventoryWriteDown
15000
us-gaap Share Based Compensation
ShareBasedCompensation
15794000
us-gaap Share Based Compensation
ShareBasedCompensation
20924000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
826000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3924000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
214000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
945000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-478000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8158000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-711000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
264000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34046000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-681000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2354000
bfly Increase Decrease In Vendor Advances
IncreaseDecreaseInVendorAdvances
1342000
bfly Increase Decrease In Vendor Advances
IncreaseDecreaseInVendorAdvances
-15646000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1440000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1092000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
441000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-423000
bfly Increase Decrease In Accrued Purchase Commitments
IncreaseDecreaseInAccruedPurchaseCommitments
1934000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-549000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-671000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
94000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3509000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38587000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-85719000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
297000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76484000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2286000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3271000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
36000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2250000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
72926000
bfly Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
228000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
228000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40837000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12565000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138650000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166828000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97813000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154263000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93800000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. As of September 30, 2024, substantially all of the Company’s cash and cash equivalents were invested in money market accounts with one financial institution. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced any significant losses on such accounts and does not believe it is exposed to any significant credit risk of its cash and cash equivalents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of September 30, 2024 one customer accounted for more than 10% of the Company’s accounts receivables. As of December 31, 2023, no customer accounted for more than 10% of the Company’s accounts receivable. No customer </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">accounted for more than 10% of the Company’s total revenue for the three and nine months ended September 30, 2024 and 2023.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The Company makes estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions about future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements. There have been no material changes to the Company’s use of estimates as described in the consolidated financial statements for the year ended December 31, 2023.</p>
CY2024Q3 us-gaap Severance Costs1
SeveranceCosts1
1254000
CY2023Q3 us-gaap Severance Costs1
SeveranceCosts1
4755000
us-gaap Severance Costs1
SeveranceCosts1
1224000
us-gaap Severance Costs1
SeveranceCosts1
8634000
CY2024Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
421000
CY2023Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
4488000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
2415000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
9214000
CY2024Q3 us-gaap Other Expenses
OtherExpenses
1675000
CY2023Q3 us-gaap Other Expenses
OtherExpenses
9243000
us-gaap Other Expenses
OtherExpenses
3639000
us-gaap Other Expenses
OtherExpenses
17848000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20561000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15421000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59705000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49384000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20561000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15421000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59705000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49384000
bfly Duration For Payment Terms
DurationForPaymentTerms
P30D
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2400000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1800000
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5700000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6700000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14300000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
15200000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
33000000.0
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
32000000.0
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.61
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.39
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
49038000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
49366000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4070000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3384000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20163000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20272000
CY2024Q3 us-gaap Inventory Net
InventoryNet
73271000
CY2023Q4 us-gaap Inventory Net
InventoryNet
73022000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45945000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43516000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24769000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18195000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21176000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25321000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93758000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150006000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
40000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
243000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4015000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4014000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97813000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154263000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8038000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9442000
CY2024Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1836000
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1613000
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
508000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
297000
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2084000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1197000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2239000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2481000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2379000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2192000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5501000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6203000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
22585000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
23425000
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
812000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
787000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
697000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
873000
CY2024Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
401000
CY2023Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
227000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
884000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
176000
CY2024Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
242000
CY2023Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
293000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
610000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
328000
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
971000
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
721000
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
971000
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
721000
CY2024Q1 bfly Increase In Number Of Equity Awards Authorized To Be Issued Percent
IncreaseInNumberOfEquityAwardsAuthorizedToBeIssuedPercent
0.04
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4412000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6815000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15794000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20924000
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
16924000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16924000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212774085
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212774085
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
27368000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27368000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
206740234
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206740234
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
54391000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-54391000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211109792
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211109792
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
89579000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-89579000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
204749108
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
204749108
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
50298302
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45219522
CY2024Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000
CY2023Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
700000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
600000
us-gaap Operating Lease Cost
OperatingLeaseCost
2200000
us-gaap Operating Lease Cost
OperatingLeaseCost
2500000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001558370-24-014082-index-headers.html Edgar Link pending
0001558370-24-014082-index.html Edgar Link pending
0001558370-24-014082.txt Edgar Link pending
0001558370-24-014082-xbrl.zip Edgar Link pending
bfly-20240930.xsd Edgar Link pending
bfly-20240930x10q.htm Edgar Link pending
bfly-20240930x10q006.jpg Edgar Link pending
bfly-20240930x10q007.jpg Edgar Link pending
bfly-20240930xex10d1.htm Edgar Link pending
bfly-20240930xex10d1001.jpg Edgar Link pending
bfly-20240930x10q_htm.xml Edgar Link completed
bfly-20240930xex31d1.htm Edgar Link pending
bfly-20240930xex31d2.htm Edgar Link pending
bfly-20240930xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
bfly-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bfly-20240930_cal.xml Edgar Link unprocessable
bfly-20240930_def.xml Edgar Link unprocessable
bfly-20240930_lab.xml Edgar Link unprocessable